Phosphorylation of Residue 131 of HIV-1 Matrix Is Not Required for Macrophage Infection  by Freed, Eric O et al.
Cell, Vol. 88, 171±174, January 24, 1997, Copyright 1997 by Cell Press
Matters Arising
mutant. Thus, the 131YF mutation had no effect on virusPhosphorylation of Residue 131
infectivity in primary human macrophage cultures evenof HIV-1 Matrix Is Not Required in the context of a mutant Vpr.
To test the possibility that the apparent discrepancyfor Macrophage Infection
between our results and those reported by Gallay et
al. (1995a) might reflect differences between the virus
isolates used in the two studies, the molecular clones
It has been suggested that the matrix (MA) domain of used in the Gallay et al. experiments were obtained from
HIV-1 Gag plays a central role in translocating the HIV-1 D. Trono (Salk Institute). The ability of these clones to
preintegration complex to the nucleus following infec- productively infect MDM was tested in parallel with our
tion of nondividing cells. Gallay et al. proposed that wild-type and 131YF mutant clones (Figure 1B). Consis-
phosphorylation of 1% of MA on a C-terminal Tyr (resi- tent with the results obtained with our wild-type and
due 131) was required to reverse the membrane binding mutant virus stocks, the macrophage-tropic isolate
properties of MA and promote an association between R7Bal and the Tyr mutant derivative MAY132F. R7Bal
MA and the integrase protein, thus enabling MA to assist replicated with indistinguishable kinetics. We note that
in translocating the HIV-1 preintegration complex to the R7Bal and MAY132F.R7Balcontain a truncated vpr gene
nucleus (Gallay et al., 1995a,b). The critical piece of (von Schwedler et al., 1994).
biological data in support of this model was that muta- It has been suggested that, in some primary macro-
tion of MA Tyr 131 to Phe blocked infection of differenti- phage systems, virus infection occurs primarily in a
ated primary human monocyte-derived macrophages small subpopulation of cells which are actively prolifer-
(MDM) (Gallay et al., 1995a). ating (Schuitemaker et al., 1994). To test whether this
To confirm this observation, we introduced the same is the case in our experiments, we determined the frac-
single amino acid substitution (Tyr to Phe) at residue tion of cells which are actively proliferating at the time
131 of MA. We initially introduced the 131YF mutation of infection and at two-weeks post-infection. This was
into the T-cell line tropic molecular clone pNL4-3, and done by labeling nuclear DNA with propidium iodide and
determined that this substitution did not affect Gag pre- using flow cytometry to determine relative DNA content,
cursor processing, virion assembly and release, or virus then quantitating the proportion of nuclei in G0/G1, S,
spread in a T-cell line (data not shown). To analyze the and G2/M phases of the cell cycle (Nicoletti et al., 1991).
effect of the 131YF substitution on infection of primary Only 0.5%-4% of nuclei were in S-phase. No significant
MDM, we introduced this mutation into the macrophage- differences in S-phase fraction were detected by com-
tropic pNL4-3 derivative pNL(AD8) (Freed and Martin, paring infected and uninfected cells, or comparing day
1994; Freed et al., 1995). HeLa cells were transfected 0 and peak infection cultures (data not shown). At peak
with pNL(AD8), pNL(AD8)131YF, or pNL4-3. Virus stocks infection, most of the cells in the infected macrophage
were prepared from the transfected cell medium, nor- cultures had fused to form large multinucleated syncy-
malized for reverse transcriptase (RT) activity, and then tia, suggesting that the virus infection had spread
used to infect MDM cultures. Virus replication in the throughout the culture. We confirmed that the majority
infected MDM cultures was monitored by RT analysis. of cells in the infected cultures were expressing HIV
Infections were repeated with several different virus RNA by in situ hybridization. More than 70% of the nuclei
stocks and cells from six different donors. In all assays, in infected cultures contained HIV-1 RNA, whereas no
the 131YF mutant replicated with kinetics indistinguish- hybridization signal was detected in nuclei from unin-
able from wild-type (Figure 1A; data not shown). As fected cultures (data not shown). Using macrophage
expected, the T-cell line restricted HIV-1 isolate pNL4-3 culture techniques similar to those employed in this
failed to productively infect the MDM cultures. To ex- study, Lazdins et al. (1991) reported that 100% of cells
clude the possibility that the virus replication observed became infected at the peak of virus production. The
in the pNL(AD8)131YF-infected MDM cultures was due fact that a very low percentage of cells displayed prolif-
to reversion of the 131YF mutation, we prepared DNA erative capacity while a high percentageof cells became
from the infected MDM cultures and PCR amplified the productively infected with both wild-type and 131YF
MA coding region. DNA sequencing indicated that the mutant viruses indicates that virus replication was not
131YF mutation was still present (data not shown). restricted to actively proliferating cells. Even in cultures
Since the virus used in the initial Gallay et al. report in which fewer than 1% of the cells displayed prolifera-
was defective for the HIV-1 accessory gene vpr (Gallay tive capacity, the 131YF mutation had no effect on virus
et al., 1995), and because it had been proposed that Vpr infectivity. The input inoculum used in our infections is
and MA contain redundant nuclear localization signals low: typically 500 RT cpm/ml (a multiplicity of infection
(Heinzinger et al., 1994), we introduced a previously de- of approximately 10-2 to 10-3). In cells from certain donors
scribed (Freed et al., 1995) vpr mutation into the pNL(A- the peak virus output reached 40,000 cpm/ml (e.g. Figure
D8)131YF clone. As reported earlier (Freed et al., 1995), 1B). This represents an 80-fold amplification of the input
the vpr mutation (R-) alone reduced peak RT production inoculum. We emphasize, however, that even in donor
by approximately two- to threefold relative to wild type cells that were infected much less efficiently, the 131YF
(Figure 1A). The 131YF/vpr double mutant (131YF/R-) mutation had no effect on virus replication (data not
shown).replicated with kinetics indistinguishable from the vpr
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131YF MA and/or Vpr mutations. In two independent
experiments, the 131YF mutation had no detrimental
effect on the kinetics of virus replication (data not
shown). Thus, differences in primary macrophage sys-
tems cannot explain the divergent results obtained in
this and the Gallay et al. studies.
We have demonstrated that: i) in cells from numerous
macrophage donors, ii) in two different primary macro-
phage purification/culture systems, iii) in the context of
two different macrophage-tropic molecular clones, and
iv) in the presence or absence of a functional vpr gene,
the 131YF mutation had no detectable effect on in-
fectivity.
Prior to the publication of the Gallay et al. papers,
Bukrinsky et al. (1993) reported that mutations in a highly
basic domain near the N-terminus of MA blocked infec-
tion of nondividing cells; it was subsequently reported
that this defect is observed only in the context of a
nonfunctional vpr gene (Heinzinger et al., 1994). We
demonstrated, however, that an extensive mutational
analysis of basic residues within the MA basic domain
failed to support the hypothesis that this domain was
required for HIV-1 infectivity in primary human MDM
(Freedand Martin, 1994; Freed et al., 1995).Furthermore,
ourdata showed that MA basic domain mutants retained
infectivity even in the context of a mutant vpr gene, and
that MA and vpr mutations displayed additive, rather
than synergistic effects in MDM infections (Freed et al.,
1995).
We emphasize that our results do not exclude a role
for MA in infection of nondividing cells. It is possible, for
example, that simultaneous phosphorylation at multiple
positions on MA, including Ser and Thr residues, may
be required to reverse the intrinsic membrane binding
properties of MA (Bukrinskaya et al., 1996). Clearly, how-
ever, simply blocking Tyr phosphorylation at MA residue
131 has no detectable effect.
Following the submission of this manuscript for publi-Figure 1. Replication Kinetics of the 131YF Mutant in Primary Hu-
cation, Bukrinskaya et al. (1996) also reported, using aman MDM
different HIV-1 isolate and different macrophage cultureVirus stocks were prepared by transfection of HeLa cells with the
conditions, that mutation of HIV-1 MA Tyr 131 had noindicated molecular clones and were used to infect MDM. Panel A:
infections with the wild-type macrophage-tropic clone pNL(AD8); effect on virus infectivity in MDM.
the pNL(AD8) derivative containing the 131YF mutation [pNL(A-
D8)131YF], the vpr mutation (R-), or both 131YF and vpr mutations Experimental Procedures
(131YF/R-); or the T-cell line restricted clone pNL4-3. Panel B: infec-
tions with pNL(AD8); R7Bal; the MA Tyr mutant derivatives pNL(A- HIV-1 Molecular Clones and Mutagenesis
D8)131YF and MAY132F.R7Bal; or pNL4-3. Virus preparations were This study utilized the T-cell line restricted HIV-1 molecular clone
normalized for RT activity, and equivalent amounts of virus were pNL4-3 for CEM(12D-7) replication assays, and the macrophage-
used to infect macrophage cultures. tropic pNL4-3 derivative pNL(AD8) (Freed and Martin, 1994; Freed
et al., 1995) for MDM experiments. Mutagenesis was performed as
described (Freed et al., 1994). The presence of the 131YF mutation
in both Vpr1 and Vpr- clones was confirmed by DNA sequencing.As described in the Experimental Procedures, the
The R7Bal and MAY132F. R7Bal molecular clones were kindly pro-macrophage system used in this study employs centrifu-
vided by D. Trono (Salk Institute).gal elutriation to enrich for monocytes. After elutriation,
the cells are allowed to fully differentiate for two weeks
Preparation and Infection of Primary Human MDM
on plastic. In the Gallay et al. report, monocytes are Techniques used to prepare and infect cultures of primary MDM
purified by adherence to plastic, without an initial elutria- have been described previously in detail (Lazdins et al., 1991; Freed
et al., 1995; Englund et al., 1995). Briefly, elutriated monocytes weretion step. To determine whether differences in technique
plated on bacteriological petri plates and allowed to differentiatemight affect the phenotype of the 131YF MA mutation,
for 14 days, after which the cells were transferred to 96-well Nuncwe purified and differentiated macrophages using the
tissue culture plates. The macrophage cultures were infected onesame methodology employed by Gallay et al. (Freundlich
day post-plating with equivalent amounts of virus, normalized for RT
and Avdalovic, 1983; Kornbluth et al., 1989). The macro- activity. For the system utilizing adherence-purified macrophages,
phages purified by adherence to plastic were then in- peripheral blood monocytes were purified from peripheral blood
mononuclear cells by adherence to gelatin/fibronectin coated tissuefected with pNL(AD8) and derivatives containing the
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culture plates (Freundlich and Avdalovic, 1983). Purified monocytes In Response to Freed et al.
were then differentiated on tissue culture plates for 7-10 days and
infected as described (Kornbluth et al., 1989). Our recent proposal that the C-terminal tyrosine phos-
phorylation of MA reveals the karyophilic potential of
Cell Cycle Analyses
this protein within the contextof theHIV-1 preintegrationDNA content of nuclei was determined as described (Nicoletti et
complex relied on a series of experiments which helpedal., 1991) by lysing plasma membranes, staining nuclear DNA with
propidium iodide, and quantitating the relative DNA content of nuclei to define the components of this complex and to identify
using the Becton-Dickinson FACSORT fluorescence activated cell their interactions among each other and with the cell
sorter. The proportion of nuclei in G0/G1, S, and G2/M was deter- nuclear import machinery, and which examined their
mined using the MODFIT DNA analysis software. intracellular trafficking during the early steps of the viral
life cycle (Gallay et al., 1995a, 1995b). Using tyrosineIn Situ Hybridization
kinase inhibitors, Bukrinskaya et al. (1996) confirmedCells were fixed and hybridized overnight in hybridization buffer
that MA tyrosine phosphorylation promotes the nuclear(Bertholdand Maldarelli, 1996) to a 32P-labeled DNA probe generated
by random priming (multiprime DNA labeling kit, Amersham) from targeting of the viral DNA and facilitates HIV-1 infection
a 5.3 kb DNA fragment including the U5-gag/pol, vif, and a portion of nondividing cells, even though they suggested that
of the vpr region of HIV-1 (pNL4-3 nucleotides 433-5743). Cells the C-terminal residuemight not be thesole phosphotyr-
were washed as described (Berthold and Maldarelli), then air dried,
osine present in MA.subjected to autoradiography, examined by microscopy, andscored
Freed et al. previously questioned the role of the MAfor HIV-1 infection when signal was present within the nuclei.
NLS in HIV-1 infection of macrophages (Freed and Mar-
tin, 1994; Freed et al., 1995). In line with this position,Eric O. Freed, George Englund, Frank Maldarelli,
they now present data contesting the participation ofand Malcolm A. Martin
the C-terminal phosphorylation of MA in this process.Laboratory of Molecular Microbiology
To address this controversy, we first compared the sta-National Institute of Allergy and Infectious Diseases
tus of MA tyrosine phosphorylation of their and our vi-National Institutes of Health
ruses. We found that in both cases the C-terminal resi-Bethesda, MD 20892-0460
due was the only phosphotyrosine of MA, in agreement
with the results of our past analyses of a number of
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